Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling
- PMID: 24976685
- PMCID: PMC4058205
- DOI: 10.1155/2014/492173
Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling
Abstract
Cancer inflammation promotes cancer progression, resulting in a high risk of cancer. Here, we demonstrate that our new herbal extract, SH003, suppresses both tumor growth and metastasis of MDA-MB-231 breast cancer cells via inhibiting STAT3-IL-6 signaling path. Our new herbal formula, SH003, mixed extract from Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii Maximowicz, suppressed MDA-MB-231 tumor growth and lung metastasis in vivo and reduced the viability and metastatic abilities of MDA-MB-231 cells in vitro. Furthermore, SH003 inhibited STAT3 activation, which resulted in a reduction of IL-6 production. Therefore, we conclude that SH003 suppresses highly metastatic breast cancer growth and metastasis by inhibiting STAT3-IL-6 signaling path.
Figures






Similar articles
-
SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the RTK-STAT3 Pathway.Anticancer Res. 2025 May;45(5):1965-1980. doi: 10.21873/anticanres.17573. Anticancer Res. 2025. PMID: 40295067
-
SH003 suppresses breast cancer growth by accumulating p62 in autolysosomes.Oncotarget. 2016 Aug 19;8(51):88386-88400. doi: 10.18632/oncotarget.11393. eCollection 2017 Oct 24. Oncotarget. 2016. PMID: 29179443 Free PMC article.
-
SH003 Inhibits Proliferation and Induces Apoptosis in NSCLC Cell Lines by Inhibiting the Receptor Tyrosine Kinase-related Pathway.Anticancer Res. 2025 May;45(5):1981-1995. doi: 10.21873/anticanres.17574. Anticancer Res. 2025. PMID: 40295074
-
State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent.Cancers (Basel). 2022 Feb 21;14(4):1089. doi: 10.3390/cancers14041089. Cancers (Basel). 2022. PMID: 35205836 Free PMC article. Review.
-
Research Progress on the Anti-Cancer Effects of Astragalus membranaceus Saponins and Their Mechanisms of Action.Molecules. 2024 Jul 18;29(14):3388. doi: 10.3390/molecules29143388. Molecules. 2024. PMID: 39064966 Free PMC article. Review.
Cited by
-
Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review).Int J Oncol. 2021 Oct;59(4):77. doi: 10.3892/ijo.2021.5257. Epub 2021 Aug 20. Int J Oncol. 2021. PMID: 34414460 Free PMC article. Review.
-
Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol.Medicine (Baltimore). 2020 Sep 18;99(38):e22228. doi: 10.1097/MD.0000000000022228. Medicine (Baltimore). 2020. PMID: 32957363 Free PMC article.
-
SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway.BMC Complement Altern Med. 2016 Dec 7;16(1):507. doi: 10.1186/s12906-016-1490-5. BMC Complement Altern Med. 2016. PMID: 27927199 Free PMC article.
-
Metabolomic Analysis of Exosomes Derived from Lung Cancer Cell Line H460 Treated with SH003 and Docetaxel.Metabolites. 2022 Oct 28;12(11):1037. doi: 10.3390/metabo12111037. Metabolites. 2022. PMID: 36355120 Free PMC article.
-
Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer.Int J Mol Sci. 2021 Aug 5;22(16):8405. doi: 10.3390/ijms22168405. Int J Mol Sci. 2021. PMID: 34445110 Free PMC article.
References
-
- Schwentner L, Wolters R, Koretz K, et al. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival-a retrospective multi-centre cohort study. Breast Cancer Research and Treatment. 2012;132(3):1073–1080. - PubMed
-
- Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clinical Cancer Research. 2007;13(15):4429–4434. - PubMed
-
- Wang S, Wu X, Tan M, et al. Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy. Journal of Ethnopharmacology. 2012;140(1):33–45. - PubMed
-
- Qi FH, Li A, Inagaki Y, et al. Chinese herbal medicines as adjuvant treatment during chemoor radio-therapy for cancer. BioScience Trends. 2010;4(6):297–307. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous